To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
New Rhein Healthcare Investors to sell stake in Softhale
New Rhein Healthcare Investors has agreed to sell its 60 percent stake in Softhale to Sino Biopharmaceutical Limited for an upfront payment of $110 million plus a profit share.
